Ledger.Open graph →
SEC Form D · filed June 1, 2023

Eikon Therapeutics, Inc

Offering
$535.0M
Sold
$140.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HAYWARD, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (36)

Dror M. Berman · Hayward, CADirectorJames M. Tananbaum · Hayward, CADirectorRoger M. Perlmutter · Hayward, CAExec · DirectorBenjamin M. Thorner · Hayward, CAExecKenneth M. Frazier · Hayward, CADirectorLeon M. Chen · Hayward, CADirectorAlfred M. Bowie · Hayward, CAExecRobin M. Washington · Hayward, CADirectorBarbara M. Howes · Hayward, CAExecTim Hauch · Eden Prairie, MNExecAlicia Glen · New York, NYDirectorNicholas Stageberg · Rochester, MNExec · DirectorRaymond Updyke · New York, NYDirectorGeorge T. Hollan · Southlake, TXDirectorChris Dewey · Eden Prairie, MNExecEric Newman · Jupiter, FLDirectorJoe D. Davis · Southlake, TXDirectorRoy M. Banes · Hayward, CAExecDan M. Anderson · Hayward, CAExecAshish M. Kheterpal · Hayward, CAExecJosh M. Wolfe · IRVINE, CADirectorRuss M. Berman · Hayward, CAExecSimon J. Cox · Central, Hong KongDirectorJoshua Stone · McKinney, TXDirectorTrevor Woolfe · Vancouver, British Columbia, CanadaExec · DirectorManasa Mantravadi · Indianapolis, INDirectorSara Beugelmans · SAN FRANCISCO, CAExecJohn Morgan · NEW YORK, NYExecBhuplesh Gupta · Scottsdale, AZDirectorMatthew Jaffee · GLENCOE, ILDirectorRoy M. Banes · Hayward, CAExecDan M. Anderson · Hayward, CAExecAshish M. Kheterpal · Hayward, CAExecJosh M. Wolfe · IRVINE, CADirectorRuss M. Berman · Hayward, CAExecBarbara M. Howes · Hayward, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗